Manganese superoxide dismutase and chemokine genes polymorphisms in Chinese patients with anterior uveitis

Investigative Ophthalmology and Visual Science

Volumn 50, Issue 12, 2009, Pages 5596-5600

  Lan, Chenghong ^a,b   Tam, Pancy O S ^a   Chiang, Sylvia W Y ^a   Chan, Carmen K M ^a   Luk, Fiona O J ^a   Lee, Gary K Y ^a   Ngai, Jasmine W S ^a   Law, Jason S S ^a   Lam, Dennis S C ^a,b   Pang, Chi Pui ^a,b   Lai, Timothy Y Y ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HLA B27 ANTIGEN; MANGANESE SUPEROXIDE DISMUTASE; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; CCL2 PROTEIN, HUMAN; CCL5 PROTEIN, HUMAN; SUPEROXIDE DISMUTASE;

ADULT; AGED; ALLELE; ARTICLE; CASE CONTROL STUDY; CCL2 GENE; CCL5 GENE; CHINESE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE; GENE FREQUENCY; GENOTYPE; HOMOZYGOSITY; HUMAN; IRIDOCYCLITIS; MAJOR CLINICAL STUDY; MALE; MANGANESE SUPEROXIDE DISMUTASE GENE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; ACUTE DISEASE; ADOLESCENT; ASIAN; GENETICS; MIDDLE AGED; POLYMERASE CHAIN REACTION;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHEMOKINE CCL2; CHEMOKINE CCL5; FEMALE; GENE FREQUENCY; GENOTYPE; HLA-B27 ANTIGEN; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; SUPEROXIDE DISMUTASE; UVEITIS, ANTERIOR; YOUNG ADULT;

EID: 73349118146     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.09-3661     Document Type: Article

References (26)

1. Chang JH, Wakefield D. Uveitis: a global perspective. Ocul Immunol Inflamm. 2002;10(4):263-279.
2. Martin TM, Kurz DE, Rosenbaum JT. Genetics of uveitis. Ophthalmol Clin North Am. 2003;16(4):555-565.
3. Martin TM, Rosenbaum JT. Genetics in uveitis. Int Ophthalmol Clin. 2005;45(2):15-30.
4. Chang JH, McCluskey PJ, Wakefield D. Acute anterior uveitis and HLA-B27. Surv Ophthalmol. 2005;50(4):364-388.
5. Levinson RD. Immunogenetics of ocular inflammatory disease. Tissue Antigens. 2007;69(2):105-112.
6. Wegscheider BJ, Weger M, Renner W, et al. Role of the CCL2/ MCP-1-2518A>G gene polymorphism in HLA-B27 associated uveitis. Mol Vis. 2005;11:896-900.
7. Kuo NW, Lympany PA, Menezo V, et al. TNF-857T, a genetic risk marker for acute anterior uveitis. Invest Ophthalmol Vis Sci. 2005; 46(5):1565-1571.
8. Tuaillon N, Shen DF, Berger RB, Lu B, Rollins BJ, Chan CC. MCP-1 expression in endotoxin-induced uveitis. Invest Ophthalmol Vis Sci. 2002;43(5):1493-1498.
9. Fang IM, Yang CH, Lin CP, Yang CM, Chen MS. Expression of chemokine and receptors in Lewis rats with experimental autoimmune anterior uveitis. Exp Eye Res. 2004;78(6):1043-1055
10. Verma MJ, Lloyd A, Rager H, et al. Chemokines in acute anterior uveitis. Curr Eye Res. 1997;16(12):1202-1208.
11. Adamus G, Manczak M, Machnicki M. Expression of CC chemokines and their receptors in the eye in autoimmune anterior uveitis associated with EAE. Invest Ophthalmol Vis Sci. 2001;42(12): 2894-2903
12. Rovin BH, Lu L, Saxena R. A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression. Biochem Biophys Res Commun. 1999;259(2):344-348.
13. Nickel RG, Casolaro V, Wahn U, et al. Atopic dermatitis is associated with a functional mutation in the promoter of the C-C che-mokine RANTES. J Immunol. 2000;164(3):1612-1616.
14. Chen Y, Vaughan RW, Kondeatis E, et al. Chemokine gene polymorphisms associate with gender in patients with uveitis. Tissue Antigens. 2004;63(1):41-45.
15. Ahad MA, Missotten T, Abdallah A, Lympany PA, Lightman S. Polymorphisms of chemokine and chemokine receptor genes in idiopathic immune-mediated posterior segment uveitis. Mol Vis. 2007;13:388-396.
16. Yeo TK, Ahad MA, Kuo NW, et al. Chemokine gene polymorphisms in idiopathic anterior uveitis. Cytokine. 2006;35(1-2): 29-35.
17. Kose K, Yazici C, Cambay N, Ascioglu O, Dogan P. Lipid peroxi-dation and erythrocyte antioxidant enzymes in patients with Behçet's disease. Tohoku J Exp Med. 2002;197(1):9-16.
18. Kiraz S, Ertenli I, Calguneri M, et al. Interactions of nitric oxide and superoxide dismutase in Behçet's disease. Clin Exp Rheumatol. 2001;19:25-29.
19. Shimoda-Matsubayashi S, Matsumine H, Kobayashi T, Nakagawa-Hattori Y, Shimizu Y, Mizuno Y. Structural dimorphism in the mitochondrial targeting sequence in the human manganese super-oxide dismutase gene: a predictive evidence for conformational change to influence mitochondrial transport and a study of allelic association in Parkinson's disease. Biochem Biophys Res Com-mun. 1996;226(2):561-565.
20. Sutton A, Khoury H, Prip-Buus C, Cepanec C, Pessayre D, Degoul F. The Ala16Val genetic dimorphism modulates the import of human manganese superoxide dismutase into rat liver mitochondria. Pharmacogenetics. 2003;13(3):145-157.
21. Xu Y, Kiningham KK, Devalaraja MN, et al. An intronic NF-kappaB element is essential for induction of the human manganese super-oxide dismutase gene by tumor necrosis factor-alpha and interleu-kin-1beta. DNA Cell Biol. 1999;18(9):709-722.
22. Nakao K, Isashiki Y, Sonoda S, Uchino E, Shimonagano Y, Sakamoto T. Nitric oxide synthase and superoxide dismutase gene polymorphisms in Behçet disease. Arch Ophthalmol. 2007;125(2): 246-251.
23. Yen JH, Tsai WC, Lin CH, Ou TT, Hu CJ, Liu HW. Cytochrome P450 1A1 and manganese superoxide dismutase gene polymorphisms in Behçet's disease. J Rheumatol. 2004;31(4):736-740.
24. Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data: results of the First International Workshop. Am J Ophthalmol. 2005;140(3):509-516.
25. Konno Y, Numaga J, Tsuchiya N, et al. HLA-B27 subtypes and HLA class II alleles in Japanese patients with anterior uveitis. Invest Ophthalmol Vis Sci. 1999;40(8):1838-1844.
26. Sutton A, Imbert A, Igoudjil A, et al. The manganese superoxide dismutase Ala16Val dimorphism modulates both mitochondrial import and mRNA stability. Pharmacogenet Genomics. 2005; 15(5):311-319.